Getein Biotech, Inc (603387.SS) SHH

8.79

+0.03(+0.34%)

Updated at August 19 09:37AM

Currency In CNY

Valuation

Market Cap4.19B
Enterprise Value4.42B
P/E Ratio18.94
PEG Ratio-2.37
Price/Sales Ratio4.09
Price/Book Ratio1.61
Enterprise/Revenue4.38
Enterprise/EBITDA20.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.21
Operating Margin0.23

Management Effectiveness

Return On Assets0.06
Return On Equity0.09

Income Statement

Revenue1.16B
Revenue/Share2.2
Gross Profit806.37M
EBITDA362.01M
Net Income223.64M
Diluted EPS0.44

Balance Sheet

Total Cash870.96M
Total Cash/Share1.76
Total Debt600.23M
Total Debt/Equity0.22
Current Ratio2.09
Book Value Per Share5.61

Price History

52-Week Change10.61
52-Week High9.74
52-Week Low6.93
Moving Average 50 Days8.33
Moving Average 200 Days8.37

Statistics

Average Volume5.67M
Shares Outstanding507.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield2.05
Payout Ratio0.46
Last Split Factor7:5
Last Split DateJune 08, 2022